Vaccine Adjuvants Recapitulate the Early Innate Response to Live Vaccination: Implications for Therapeutic Cancer Vaccine Design
Abstract
Background: : /Objectives: Therapeutic cancer vaccines can generate measurable immunity without tumor regression. Adjuvants initiate innate activation, but antitumor efficacy also requires antigen presentation, lymphoid priming, effector differentiation, tumor trafficking, cancer-cell recognition and killing, and persistence. We compared the magnitude, duration, and downstream breadth of clinically used adjuvant responses with live vaccination.
Methods:: We reanalyzed transcriptomic data from six randomized human vaccine studies and one controlled mouse experiment; one human study sequenced six sorted leukocyte populations. Twenty-three prespecified gene sets spanning innate ignition, antigen presentation, adaptive differentiation, trafficking, and effector programs were scored by participant-paired, baseline-adjusted comparisons with matched controls. One trial sampled placebo, adjuvanted, unadjuvanted, and live attenuated vaccines daily.
Results:: AS01B, AS01E, AS03, and MF59 increased type I interferon by 9.6, 8.6, 7.5, and 3.2 percentile points at 24 hours; AS04 and aluminum salt remained at control levels. Yellow fever 17D sustained interferon through day 7; MF59 resolved by day 3 and AS01/AS03 by day 7. Antigen-presenting-cell activation and MHC class I machinery rose with interferon. Apart from a small day-7 germinal-center/plasmablast signal in two AS03 trials, no reproducible sustained downstream program was detected in blood; acute cytotoxic and natural-killer-cell…
How strong is the evidence?
Evidence Hub reads this as a randomized trial. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
- Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials
- Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta‐analysis, and network meta‐analysis of randomized trials with 94,283 participants
- Screen time increases overweight and obesity risk among adolescents: a systematic review and dose-response meta-analysis
- Exposure to WHO AWaRe antibiotics and isolation of multi-drug resistant bacteria: a systematic review and meta-analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.